[Alteration of blood coagulation and fibrinolysis after intra-arterial one-shot chemotherapy in liver cancer]. 1983

Y Suyama, and S Seki, and Y Tanaka, and M Tada, and H Fujii, and M Miyoshi, and S Nishimura, and T Nishitani, and K Katake

Twenty liver cancer patients, including 9 hepatocellular carcinoma and 11 with metastatic liver cancer, were treated by intra-arteral one-shot chemotherapy. Alterations in blood coagulation and fibrinolysis were observed serially after one-shot chemotherapy by testing the levels of PT, APTT, FDP, fibrinogen, AT III, alpha 2-macroglobulin, and plasminogen. APTT was prolonged, FDP increased, Fbg increased after a transicent decrease, and AT III, alpha 2-M, and plasminogen decreased. The peaks of these alterations occurred within 7 days after the one-shot treatment; recovery was observed after about weeks. The more advanced the cancer, the greater were the alterations.

UI MeSH Term Description Entries
D007269 Injections, Intra-Arterial Delivery of drugs into an artery. Injections, Intraarterial,Intra-Arterial Injections,Intraarterial Injections,Injection, Intra-Arterial,Injection, Intraarterial,Injections, Intra Arterial,Intra Arterial Injections,Intra-Arterial Injection,Intraarterial Injection
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D016685 Mitomycin An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis. Mitomycin C,Ametycine,Mitocin-C,Mitomycin-C,Mutamycin,NSC-26980,Mitocin C,MitocinC,NSC 26980,NSC26980

Related Publications

Y Suyama, and S Seki, and Y Tanaka, and M Tada, and H Fujii, and M Miyoshi, and S Nishimura, and T Nishitani, and K Katake
January 1987, Cancer chemotherapy and pharmacology,
Y Suyama, and S Seki, and Y Tanaka, and M Tada, and H Fujii, and M Miyoshi, and S Nishimura, and T Nishitani, and K Katake
May 1985, Gan no rinsho. Japan journal of cancer clinics,
Y Suyama, and S Seki, and Y Tanaka, and M Tada, and H Fujii, and M Miyoshi, and S Nishimura, and T Nishitani, and K Katake
February 1971, Saishin igaku. Modern medicine,
Y Suyama, and S Seki, and Y Tanaka, and M Tada, and H Fujii, and M Miyoshi, and S Nishimura, and T Nishitani, and K Katake
January 1983, Indian journal of cancer,
Y Suyama, and S Seki, and Y Tanaka, and M Tada, and H Fujii, and M Miyoshi, and S Nishimura, and T Nishitani, and K Katake
August 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Suyama, and S Seki, and Y Tanaka, and M Tada, and H Fujii, and M Miyoshi, and S Nishimura, and T Nishitani, and K Katake
September 1996, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Suyama, and S Seki, and Y Tanaka, and M Tada, and H Fujii, and M Miyoshi, and S Nishimura, and T Nishitani, and K Katake
January 1994, European journal of cancer (Oxford, England : 1990),
Y Suyama, and S Seki, and Y Tanaka, and M Tada, and H Fujii, and M Miyoshi, and S Nishimura, and T Nishitani, and K Katake
October 1985, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
Y Suyama, and S Seki, and Y Tanaka, and M Tada, and H Fujii, and M Miyoshi, and S Nishimura, and T Nishitani, and K Katake
August 1984, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
Y Suyama, and S Seki, and Y Tanaka, and M Tada, and H Fujii, and M Miyoshi, and S Nishimura, and T Nishitani, and K Katake
March 1987, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Copied contents to your clipboard!